8-K: Acadia Healthcare Appoints Todd Young as New CFO

Acadia Healthcare Company, Inc. announced the appointment of Todd Young, an executive with 25 years of financial and healthcare experience, as its new Chief Financial Officer, effective October 27, 2025.

Summary

• Acadia Healthcare Company, Inc. (ACHC) has appointed Todd Young as its Chief Financial Officer, effective October 27, 2025.
• Mr. Young, age 54, brings nearly a decade of executive-level finance experience from publicly traded healthcare companies, including serving as CFO at Elanco Animal Health and ACADIA Pharmaceuticals Inc.
• Timothy Sides, who has been serving as Interim CFO since August 2025, will resume his role as Senior Vice President, Operations Finance.
• Mr. Young's compensation package includes an annualized base salary of $725,000, eligibility for a target annual cash bonus of 85% of base salary (starting 2026), and a one-time cash award of $460,000.
• He will also receive a one-time grant of time-based restricted stock units (RSUs) with a grant date fair value of $1,200,000, vesting ratably over three years.
• Annual long-term incentive awards, commencing with the 2026 fiscal year, will have an aggregate grant date fair value of no less than $2,900,000.
• The company will reimburse Mr. Young for reasonable relocation expenses to the greater Franklin, Tennessee area within 12 months of his start date.
• Acadia Healthcare operates 274 behavioral healthcare facilities with approximately 12,100 beds in 39 states and Puerto Rico, serving over 82,000 patients daily with approximately 25,000 employees as of June 30, 2025.

Sentiment

Score: 8

Explanation: The appointment of a highly experienced CFO with a strong track record in publicly traded healthcare companies is a significant positive for the company's financial leadership and strategic execution. The detailed compensation package and clear transition plan indicate a well-managed executive search and onboarding process.

Positives

• Todd Young brings extensive executive-level finance experience (25 years) from publicly traded healthcare companies, including prior CFO roles at Elanco Animal Health and ACADIA Pharmaceuticals Inc.
• His background includes expertise in capital allocation, finance, treasury, and a track record of delivering strong financial and operational results.
• The appointment aligns with Acadia's strategy focused on disciplined growth, expanding access to behavioral healthcare, improving clinical outcomes, and driving operational efficiency.
• The company is the largest stand-alone behavioral healthcare company in the U.S., indicating a strong market position.

Risks

• The employment agreement includes non-compete and non-solicit clauses for 12 months post-employment, which could limit Mr. Young's future career options if he were to leave the company under certain circumstances.
• The effectiveness of certain severance benefits is contingent upon Mr. Young signing and not revoking a general release of claims.

Future Outlook

Acadia's leadership team is focused on building on current progress to position the company for long-term success and value creation, emphasizing disciplined growth to expand access to behavioral healthcare, improving clinical outcomes, and driving operational efficiency across its network.

Management Comments

• "On behalf of the Board and all of us at Acadia, I’m excited to welcome Todd to the team. Todd has excelled at leading teams at publicly traded companies and has deep expertise in capital allocation, finance, and treasury. I am confident that his track record of delivering strong financial and operational results will be instrumental to the execution of our strategy centered on disciplined growth to expand access to behavioral healthcare, improving clinical outcomes and driving operational efficiency across our network." Chris Hunter, CEO of Acadia.
• "I thank Tim for his leadership while serving as interim CFO. We appreciate his support in ensuring a seamless transition and look forward to continuing to benefit from Tim’s finance and operational expertise. As we look ahead, our entire team is focused on building on the progress we have made to position Acadia for long-term success and value creation." Chris Hunter, CEO of Acadia.
• "It is an honor to join Acadia, an organization that transforms the lives of patients through its leadership in behavioral health and addiction treatment services. I look forward to working closely with Chris and the rest of the leadership team to drive operational excellence and deepen financial discipline across the organization to support this vitally important mission." Todd Young, incoming CFO.

Industry Context

Acadia Healthcare is a leading provider in the U.S. behavioral healthcare sector, operating a vast network of facilities. The appointment of an experienced CFO like Todd Young, with a background in both animal health and biopharmaceutical sectors, suggests a strategic focus on financial discipline and operational efficiency, which are critical in the evolving and often complex healthcare industry. This move reinforces the company's commitment to its growth strategy and market leadership in a sector experiencing increasing demand for services.

Comparison to Industry Standards

• The compensation package for the incoming CFO, including a base salary of $725,000 and significant equity awards, appears competitive for a CFO of a large, publicly traded healthcare company like Acadia, which is the largest stand-alone behavioral healthcare company in the U.S. (274 facilities, 12,100 beds).
• Todd Young's previous roles as CFO at Elanco Animal Health (a global animal health company with significant market capitalization) and ACADIA Pharmaceuticals Inc. (a biopharmaceutical company) demonstrate experience in managing complex financial operations within regulated healthcare-related industries, which is a strong fit for Acadia's scale and operational footprint.
• The inclusion of a robust severance package, including 12 months of base salary and accelerated equity vesting for qualifying terminations, is consistent with executive employment agreements in the U.S. public company landscape, designed to attract and retain top-tier talent.

Management Changes

Corporate Governance

Stakeholder Impact

• **Shareholders**: The appointment of an experienced CFO is likely to be viewed positively, potentially enhancing investor confidence in the company's financial management and strategic execution, which could positively impact share price.
• **Employees**: The seamless transition of the interim CFO back to his previous role and the clear communication around the new CFO's appointment suggest stability in leadership, which can be positive for employee morale.
• **Customers/Patients**: The new CFO's focus on 'operational excellence and deepening financial discipline' is intended to support the company's mission of 'transforming the lives of patients through its leadership in behavioral health and addiction treatment services,' potentially leading to improved service delivery and access.

Next Steps

• Todd Young will officially assume the role of Chief Financial Officer on October 27, 2025.
• Timothy Sides will resume his role as Senior Vice President, Operations Finance, effective October 27, 2025.
• Todd Young is required to relocate his principal residence to the greater Franklin, Tennessee area within 12 months of his start date.
• Todd Young will be eligible for annual cash bonuses starting with the year ended December 31, 2026.
• Todd Young will receive annual grants of long-term incentive awards beginning with the 2026 fiscal year.

Key Dates

Recommendation

The appointment of Todd Young as CFO is a strong positive signal. His extensive experience as a CFO at other publicly traded healthcare companies, coupled with his expertise in capital allocation and driving operational efficiency, aligns well with Acadia's stated strategy for disciplined growth and improving clinical outcomes. This move strengthens the executive team and is likely to instill greater confidence among investors regarding the company's financial stewardship and future strategic execution. While not a direct financial performance update, a high-caliber executive hire can significantly de-risk future operations and enhance long-term value creation, making it an opportune time for a 'buy' recommendation.

Keywords

Acadia Healthcare, CFO appointment, Todd Young, Chief Financial Officer, executive change, behavioral healthcare, financial leadership, corporate governance, ACHC, management